Clopidogrel therapy in ophthalmic procedures: a survey of subspecialty ophthalmologists and review of current guidelines
| Autor: | Tiiu M. Hess, Eugene S. Liu |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Health Knowledge
Attitudes Practice medicine.medical_specialty Ticlopidine medicine.medical_treatment MEDLINE Ophthalmologic Surgical Procedures Subspecialty Coronary stent Humans Medicine Oculoplastics cardiovascular diseases Myocardial infarction business.industry Thrombosis General Medicine Perioperative medicine.disease Clopidogrel Health Surveys Ophthalmology Practice Guidelines as Topic Emergency medicine Physical therapy Guideline Adherence business Platelet Aggregation Inhibitors circulatory and respiratory physiology medicine.drug |
| Zdroj: | Canadian Journal of Ophthalmology. 46:528-530 |
| ISSN: | 0008-4182 |
| Popis: | Objective To assess the knowledge and practice of subspecialty ophthalmologists with respect to perioperative clopidogrel therapy in ophthalmic procedures. Design Mail survey composed of 5 questions. Participants Fifteen subspecialty ophthalmologists (3 in each of the fields of surgical retina, anterior segment, oculoplastics, strabismus, and glaucoma) in 3 academic centers in Toronto, Ontario. Methods Study parcipants completed an anonymous mail survey consisting of multiple-choice and short-answer questions. We studied participants' knowledge about and clinical practices regarding the use of clopidogrel in the perioperative period of specified ophthalmic procedures. We evalutated perceived risks of halting clopidogrel indicated for both primary and secondary prevention of cardiovascular events, as well as clinical decisions regarding clopidogrel in the perioperative period of specified ophthalmic procedures. Results There was marked variability and relative lack of knowledge by subspecialty ophthalmologists in the management of clopidogrel in the perioperative period. Only 1 respondent identified coronary stent thrombosis or restenosis as a potential and life-threatening risk of halting clopidogrel therapy in these patients. Conclusions In patients with coronary stents, the risks of halting clopidogrel therapy in the perioperative period are potentially life-threatening and include stent thrombosis and myocardial infarction. Ophthalmic surgeons should pay close attention to the indications for clopidogrel therapy in their patients and should enlist appropriate collaboration with their colleagues in cardiology to minimize risks to their patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect